Using digital engagement to increase medication adherence is our novel solution to a complex problem. With non-adherence caused by multiple factors unique to each individual patient, a-one-size-fits-all-solution can’t work and won’t work. Instead, at MEMOTEXT we personalize each patient’s support program. By encouraging patient input, adapting to changes in mood and lifestyle, we can develop a medication adherence and support program that works best.
Like many other great ideas we came about this solution by accident. Before the days of Outlook and smartphones, my wife would send me long emails with multiple to-dos. I always wanted a tool that would let me know EXACTLY when I needed to know something, as opposed to parsing and prioritizing all the things in her email. So I built a web-based reminder program and launched it on the web direct-to-consumer for $10 a month. It was created as a ‘virtual nagging machine’ but we saw that people started using it as a medication reminder. The light bulb went off.
Not taking your pills might not seem like that big a deal, but medication adherence is one of the biggest problems facing healthcare. Called “The world’s other drug problem” by the WHO 50% of patients do not take their medication as prescribed. In the United States alone, it is responsible for 125,000 deaths each year and costs the healthcare system $290 billion annually. With poor medication adherence responsible for up to 69% of medication related hospital admissions, and $188 billion in lost annual revenues for pharmaceutical companies, the entire healthcare system is affected. By keeping patients healthy, making pharma money and saving hospitals money, we offer a win-win-win solution that benefits the entire healthcare industry.
By embracing mobile and digital technology we can do so much more than just remind patients. We collect disparate sources of data from patient self-report, claims, wearables and EMRs to create personalized, relevant, long-term personalized digital health outreach. Then with the help of our self-learning algorithms we can educate, motivate and support our patients with relevant content. We listen for cues and guide our patients by engaging them with the right content at the right time in the right context.
With MEMOTEXT, it’s all about ‘the why’. We try to understand why people don’t adhere to their medications and try to mitigate that. We’re not just reminding them they’re sick, but helping them engage with, and ultimately empower them to take control of their health even if it’s for just 30 seconds a day.
But in order to keep our patients interacting with us we need to keep them engaged. The more they interact, the more data we get. And the more data we get the better we can adapt to our medication adherence programs to our patient’s needs. “Take your pills! Take your pills! Take your pills!” is annoying but “5 Delicious Treats While Managing Diabetes” might get our patient’s attention. It’s not about nagging them but nudging them. It’s about empathy. It’s about listening to what patients want. It’s about cat memes + health data = positive behavior change.
It’s remarkable to be running over 18 digital personalized medication adherence programs internationally using technology that didn’t even exist 10 years ago. Modern communications lets us scale our solution like never before. Scaling behavior change is now possible. We do that by taking the cost out of the healthcare conversation and by building relevance through health data. And we have the data to prove it, check out the results from our latest successful digital asthma adherence intervention HealthNHand!
Amos brings speech, mobile and social technologies together to create mobile (mHealth) and telehealth patient adherence programs. Since 2008, Amos has led the design and deployment of dozens of digital patient adherence and behavior change programs globally while advocating for evidence-based approaches to technology-based behavior change. With a background in user oriented design methodologies, user-requirements elicitation, finance and enterprise scale technology deployment, Amos focuses on solutions solving real-world business requirements with patient centered designs while understanding the challenges of change management in clinical settings.
Prior to founding MEMOTEXT, Amos held multiple technology and finance related positions within the Bell Canada Holdings family of companies as well as a background in social and private real estate development. Amos holds a M.Sc. in Analysis, Design and Management of Information Systems from The London School of Economics in London England, graduating with distinction was highlighted by his work within the launch of the world’s first independent exchange for international wholesale telecom capacity.
Amos speaks regularly at events such as: mHealth, Stanford Medicine X, Health Datapalooza, Genentech FutureMed2.0 and guest lectures at the Univ. of Toronto.